Latest News

Why Worthington Enterprises (WOR) is on investors’ radar now Worthington Enterprises (WOR) has drawn fresh attention after a recent stretch that includes a one-month return of about a 17% decline and a past three-month move of roughly a 10% decline, prompting closer scrutiny of its valuation and fundamentals. See our latest analysis for Worthington Enterprises. That recent 17% one month share price decline and 10% three month share price decline contrasts with a 21.34% one year total...

Iveco Group (BIT:IVG) is back in focus after reaffirming and expanding its partnership with Microvast, a move centered on electric battery systems that support Iveco electric bus and heavy truck platforms across Europe. See our latest analysis for Iveco Group. The reaffirmed Microvast partnership and the recent launch of the Beyond Lab open innovation platform come as Iveco Group’s €19.155 share price sits on a 1-year total shareholder return of 19.41% and a 3-year total shareholder return of...

Why GMO internet (TSE:4784) is back on investors’ radar GMO internet (TSE:4784) has put two major decisions on the table: a ¥3.2 billion GPU cloud partnership with Turing Inc., and a planned exit from its digital asset business in Thailand. See our latest analysis for GMO internet. Despite the recent board decisions, momentum has been weak, with the share price at ¥714.0 and a year to date share price return of a 23.88% decline, set against a 70.93% three year total shareholder return that...

In March 2026, One Software Technologies Ltd reported full-year 2025 results showing sales of ILS 4,650.8 million and net income of ILS 262.76 million, both higher than the prior year. The increase in basic and diluted earnings per share from continuing operations to ILS 3.66 suggests improved profitability on a per-share basis. Next, we will examine how this earnings-driven improvement in profitability shapes One Software Technologies’ investment narrative for investors. Capitalize on the...

Jazz Pharmaceuticals and its partners recently presented one oral and six poster studies at the 2026 American Association for Cancer Research Annual Meeting, highlighting progress across its oncology portfolio, including new data on HER2-targeted bispecific antibody Ziihera and investigational cytokine pro-drug JZP898. These presentations offer fresh insight into Jazz’s emerging oncology pipeline, particularly its bispecific antibody and cytokine pro-drug platforms that could broaden future...

In the past quarter, Sone Capital Management disclosed selling 162,022 Paylocity Holding shares for about US$24.11 million, as the company issued fiscal 2026 guidance of roughly US$1.70 billion in revenue with steady margin expansion. Despite this outlook, recent updates pointed to underwhelming 13% annual recurring revenue growth and expected slowing sales, highlighting emerging pressures on Paylocity’s growth engine. We’ll now examine how this softer recurring revenue trajectory and...

EverCommerce (EVCM) drew investor attention after reporting fourth quarter and full year 2025 results that shifted from prior net losses to net income, alongside the launch of its EverHealth Scribe AI documentation tool. See our latest analysis for EverCommerce. The swing to net income and the EverHealth Scribe launch come after a 90 day share price decline of 14.39% and a year to date share price decline of 10.39%. In contrast, the 1 year total shareholder return of 2.68% and 3 year total...

Lockheed Martin (LMT) is in focus after Greece moved to allocate more than US$1.15b for upgrading 38 F-16C fighter jets to F-16 Vipers, underscoring fresh international demand for its aircraft programs. See our latest analysis for Lockheed Martin. The Greece F-16 upgrade news lands at a time when Lockheed Martin’s share price has eased in the very short term, with a 1-day share price return of 1.58% and a 7-day share price return of 2.87%. However, the 90-day share price return of 29.75% and...

In March 2026, Televox, part of WestCX under West Technology Group, announced it had expanded its deployment of Rich Communication Services (RCS) powered by Twilio, supporting secure, branded, and interactive messaging for healthcare and other regulated industries using Twilio’s global infrastructure. This expansion underscores Twilio’s role in enabling higher-engagement, compliant communications in tightly regulated settings, where trust, verification, and reliable delivery are essential...

BSP Financial Group (ASX:BFL) has flagged a leadership reshuffle, appointing Group Chief Operating Officer Nuni Kulu to an expanded Group Executive, Pacific Markets role, and confirming Deputy Group Chief Executive Officer Peter Beswick’s planned retirement. See our latest analysis for BSP Financial Group. The executive reshuffle arrives after a mixed period for the shares, with recent pressure reflected in a 30 day share price return of 4.45% and a year to date share price return of a 1.21%...

Core Scientific (CORZ) is drawing attention after securing a US$500 million loan facility from Morgan Stanley to support its push into high performance computing, as well as a new data center partnership with the Cadillac Formula 1 Team. See our latest analysis for Core Scientific. Despite the headlines around high performance computing expansion and the Cadillac Formula 1 partnership, the share price is down over the past month, with a 30 day share price return of an 8.61% decline. However,...

Why AstraZeneca is on investors’ radar today AstraZeneca (LSE:AZN) has attracted fresh attention after a recent pullback, with the share price down about 9% over the past month, while performance over the past three months remains slightly positive. For investors tracking large pharma, that move is being considered alongside AstraZeneca’s £215.5b market value, revenue of £58,739.0m and net income of £10,225.0m, as well as its current £138.96 share price. See our latest analysis for...

Reliance (RS) has been on investors’ radar after its recent name change from Reliance Steel & Aluminum Co., which highlights its broader role as a diversified metal solutions provider across the US and Canada. See our latest analysis for Reliance. The recent pullback, including an 8.9% 30‑day share price decline to around $290.56, sits against a 6.5% 1‑year total shareholder return and 102.6% over five years. This suggests long‑term momentum despite softer near‑term sentiment. If Reliance’s...

Kymera Therapeutics (KYMR) is back in focus after announcing that Phase 1b data for its oral STAT6 degrader KT-621 will appear in a late-breaking oral session at the 2026 American Academy of Dermatology meeting. See our latest analysis for Kymera Therapeutics. At a share price of US$77.91, Kymera’s 1 year total shareholder return of 139.43% and 3 year total shareholder return of 165.63% point to strong momentum, even with a 10.86% 1 month share price decline and recent profit taking by...

Hugo Boss (XTRA:BOSS) is back on investor radars after recent share price moves, with the stock closing at €36.62. That puts current performance in the context of a modestly positive year to date return. See our latest analysis for Hugo Boss. The recent pullback, including a 0.73% 7 day share price return and a 1.19% 30 day share price return, sits against a 3.8% 1 year total shareholder return and a weaker 3 year total shareholder return. This hints at mixed but stabilising momentum. If this...

Recent performance context Regeneron Pharmaceuticals (REGN) has recently drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months despite a positive 1 year total return. See our latest analysis for Regeneron Pharmaceuticals. The recent 6% 1 month share price decline and slightly negative year to date share price return contrast with an 11.9% 1 year total shareholder return. This suggests that...

Scotts Miracle-Gro (SMG) just launched the Inspired to Gro Patio Garden Collection with Bonnie Plants and Gardenuity, packaging nutrients, starter plants and a guided digital platform into one offering for new gardeners. See our latest analysis for Scotts Miracle-Gro. That launch lands after a mixed stretch for investors, with a 1-month share price return of a 10.99% decline, a 90-day share price return of 5.15%, and a 1-year total shareholder return of 12.19%. This suggests momentum has been...

BOK Financial (BOKF) has drawn fresh attention after recent price moves, with the stock around $125.07 and a decline of about 7% over the past month, contrasting with a gain over the past 3 months. See our latest analysis for BOK Financial. The recent 7% 1 month share price pullback contrasts with a 3.07% 3 month share price return and a 25.29% 1 year total shareholder return, which may indicate that longer term momentum remains intact even as near term sentiment cools. If BOK Financial has...

Neurocrine Biosciences (NBIX) is drawing attention after recent trading left the shares about 13% lower over the past 3 months and roughly 9% lower year to date, despite positive annual revenue and net income growth. See our latest analysis for Neurocrine Biosciences. At a latest share price of $127.68, the stock’s short term share price momentum has been soft, yet the 1 year total shareholder return of 14.08% and 3 year total shareholder return of 31.56% indicate a stronger longer term...

Why Cheniere Energy Partners is Back in Focus A missile attack on Qatar's Ras Laffan industrial complex has removed a meaningful slice of global LNG supply, tightening the market and lifting spot prices, which directly affects Cheniere Energy Partners (NYSE:CQP). See our latest analysis for Cheniere Energy Partners. The share price reaction has been strong, with Cheniere Energy Partners trading at $67.03 and showing a 12.28% 1 month share price return and 25.88% 3 month share price return...

BRP stock moves and recent performance snapshot BRP (TSX:DOO) has attracted fresh attention after a stretch of weaker share performance, with the stock showing a 24% decline over the past month and a 16% decline over the past 3 months. See our latest analysis for BRP. That recent 24% one month share price decline comes after a strong 1 year total shareholder return of 62.31%, so recent momentum is fading even though longer term holders remain ahead. If BRP’s volatility has you reassessing...

In recent commentary, Rush Enterprises, the largest integrated commercial vehicle retailer in the US, has highlighted ongoing end-market pressures as annual sales declined by 3.1% over the past two years and earnings per share also fell. At the same time, the company is increasingly leaning on its higher-margin parts and service operations, supported by a proprietary distribution network and managed accounts strategy, to counter softer truck demand. We’ll now examine how Rush Enterprises’...

BKS Bank (WBAG:BKS) recently attracted attention after screening as a higher value score name, with an intrinsic discount of 61.02% and a market value of about €950.76m based on its latest close of €20.80. See our latest analysis for BKS Bank. The current €20.80 share price sits against a 30 day share price return of 2.97% and a 90 day share price return of 15.56%. The 1 year total shareholder return of 32.21% and 5 year total shareholder return of 92.76% indicate that momentum has been...

Capgemini (ENXTPA:CAP) has remained in focus after a stretch of weaker share performance, with the stock down about 5.7% over the past month and roughly 31.8% over the past 3 months. See our latest analysis for Capgemini. Beyond the recent setbacks, Capgemini’s share price return has been weak both in the short term and over longer horizons, with the 1 year total shareholder return decline of 30.95% highlighting pressure on sentiment despite its €98.58 share price today. If you are...